Cysal Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Cysal General Information
Description
Developer of biotechnological products designed to provide assistance in the production of dipeptides. The company's products focus on developing, optimizing, and licensing microbial metabolic diversity and fermentation processes for biopolymers and low-molecular-weight compounds, enabling researchers to replace chemical approaches for the production of specialty and base commodities.
Contact Information
Website
www.cysal.de
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Specialty Chemicals
Drug Discovery
Primary Office
- Mendelstraße 11
- 48149 Munster
- Germany
+49 0251 0000000
Cysal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Mar-2021 | 00.000 | Completed | Generating Revenue | ||
| 2. Seed Round | 08-Nov-2012 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 1. Grant | Completed | Startup |
Cysal Patents
Cysal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3056156-A1 | Aspartyl-dipeptides for skin care and cosmetic use | Pending | 24-Mar-2016 | 00000000 | |
| EP-3439626-A1 | Aspartyl-dipeptides for skin care and cosmetic use | Active | 24-Mar-2016 | 00000000 | |
| EP-3439626-B1 | Aspartyl-dipeptides for skin care and cosmetic use | Active | 24-Mar-2016 | 00000000 | |
| ES-2859651-T3 | Aspartyl dipeptides for skin care and cosmetic use | Active | 24-Mar-2016 | 00000000 | |
| US-11020337-B2 | Aspartyl-dipeptides for skin care and cosmetic use | Active | 24-Mar-2016 | A61K8/64 |
Cysal Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ahmed Sallam | Co-Founder, Chief Executive Officer & Managing Director |
Cysal Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cysal Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| eCAPITAL entrepreneurial Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Federal Ministry for Economic Affairs and Energy | Limited Partner | 000 0000 | 000000 0 |